Literature DB >> 11599603

Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol.

W C Duer1, K L Byers, J V Martin.   

Abstract

The most common chemicals that can be ingested and lead to greater than endogenous levels of gamma-hydroxybutyric acid (GHB) in decedents are salts of GHB, gamma-butyrolactone (GBL), and 1,4-butanediol (BD). Results for three deaths involving the ingestion of one or another of these three chemicals, which led to findings of GHB in the decedents, are presented. An extraction procedure that facilitates the quantitation of GHB was developed. If present in the same specimen, both GHB and GBL can be quantitated. To determine the GBL concentration, the specimen is first analyzed for existing GHB, the GBL is then converted to GHB, and the analysis is repeated. The difference between the results in molarity units can yield the GBL concentration. A separate procedure was utilized for estimating concentrations of BD. Specimens analyzed included urine, blood, ocular fluid, brain, and solutions consumed by the decedents prior to death. The procedures were found to be convenient in as much as they are relatively rapid, precise, and economical.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599603     DOI: 10.1093/jat/25.7.576

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  7 in total

1.  Inhibition of 1,4-butanediol metabolism in human liver in vitro.

Authors:  Daniel Lenz; Martin Jübner; Katja Bender; Annette Wintermeyer; Justus Beike; Markus A Rothschild; Herbert Käferstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

2.  The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion.

Authors:  Paul I Dargan; Jenny Button; Susie Davies; John Ramsey; Simi George; David W Holt; David M Wood
Journal:  J R Soc Med       Date:  2009-12       Impact factor: 5.344

3.  Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.

Authors:  Amy K Goodwin; K Michael Gibson; Elise M Weerts
Journal:  Drug Alcohol Depend       Date:  2013-03-26       Impact factor: 4.492

4.  Forensic toxicology findings in deaths involving gamma-hydroxybutyrate.

Authors:  Fredrik C Kugelberg; Anita Holmgren; Arne Eklund; Alan Wayne Jones
Journal:  Int J Legal Med       Date:  2008-12-02       Impact factor: 2.686

5.  Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs.

Authors:  Hilke Andresen-Streichert; P Jensen; J Kietzerow; M Schrot; N Wilke; E Vettorazzi; A Mueller; S Iwersen-Bergmann
Journal:  Int J Legal Med       Date:  2014-08-02       Impact factor: 2.686

6.  Liquid ecstasy - a significant drug problem.

Authors:  Hilke Andresen; Thomas Stimpfl; Nadine Sprys; Tino Schnitgerhans; Alexander Müller
Journal:  Dtsch Arztebl Int       Date:  2008-09-05       Impact factor: 5.594

7.  Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.

Authors:  Amy K Goodwin; Barbara J Kaminski; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2012-09-04       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.